Rap1 is a component of the shelterin complex at mammalian telomeres, but its in vivo role in telomere biology has remained largely unknown to date. Here we show that Rap1 deficiency is dispensable for telomere capping but leads to increased telomere recombination and fragility. We generated cells and mice deleted for Rap1; mice with Rap1 deletion in stratified epithelia were viable but had shorter telomeres and developed skin hyperpigmentation in adulthood. By performing chromatin immunoprecipitation coupled with ultrahigh-throughput sequencing, we found that Rap1 binds to both telomeres and to extratelomeric sites through the (TTAGGG) 2 consensus motif. Extratelomeric Rap1-binding sites were enriched at subtelomeric regions, in agreement with preferential deregulation of subtelomeric genes in Rap1-deficient cells. More than 70% of extratelomeric Rap1-binding sites were in the vicinity of genes, and 31% of the genes deregulated in Rap1-null cells contained Rap1-binding sites, suggesting a role for Rap1 in transcriptional control. These findings place a telomere protein at the interface between telomere function and transcriptional regulation.
Rap1 (or Terf2ip) is part of shelterin at mammalian telomeres, also encompasing TRF1, TRF2, POT1, TPP1 and TIN2 (ref. 1) . Human hRap1 was identified by homology with budding-yeast scRap1 (refs 2, 3) . scRap1 binding to telomeres controls telomere length and subtelomeric silencing [4] [5] [6] [7] [8] [9] [10] . scRap1 also controls the expression of glycolytic enzymes and ribosomal genes 11, 12 . Whereas scRap1 binds telomeric DNA directly, hRap1 its recruited to telomeres by TRF2 (ref. 3) . Overexpression of human Rap1 (hRap1) in cells leads to continuous telomere lengthening 3 . Roles of hRap1 in transcriptional regulation and subtelomeric (S) gene silencing are unknown.
Here we study the role of mouse Rap1 in telomere biology and its impact on gene expression programs and organismal viability by generating cells and mice conditionally deleted for Rap1 in a tissue-specific manner. We show that mammalian Rap1 is dispensable for telomere capping but prevents telomere recombination and fragility. Similar findings were recently reported for an independent Rap1 knock-out allele 13 . In contrast to analogous mouse models for TRF1 and TPP1 deficiency 14, 15 , which have 100% perinatal mortality, targeted Rap1 deletion to stratified epithelia does not affect mouse viability but leads to skin hyperpigmentation in adulthood and the presence of shorter telomeres.
We find that Rap1 binds to both telomeric and extratelomeric TTAGGG repeats. Extratelomeric Rap1-binding sites are enriched at S regions, in agreement with preferential derepression of S genes in Rap1-deficient cells. This result suggests a role of Rap1 in repression of S genes, analogous to that of yeast and Trypanosoma brucei Rap1 proteins 16 . Notably, more than 70% of Rap1-binding sites are found at intragenic positions or in the vicinity of gene-coding chromatin. We further show that more than one-third of the genes deregulated in Rap1-deficient cells contain Rap1-binding peaks. Thus, we identify Rap1 as an important factor to prevent telomere recombination and fragility, and for transcriptional gene regulation in mammals. These findings provide evidence that a shelterin component can bind to non-telomeric regions and have extratelomeric functions.
REsulTs

Rap1 conditional knockout mice and cells
We generated a conditional Rap1 knockout allele, Rap1 flox/flox (Fig. 1a ) 17 . Deletion of Rap1 E3 eliminates the Rap1 telomere localization domain (RCT) and the nuclear localization signal (NLS), and also disrupts the 3ʹ untranslated region and polyadenylation signal (Fig. 1b) .
Although both wild-type (WT) and Rap1 flox/flox mouse embryonic fibroblasts (MEFs) infected with pBabe-Cre did not proliferate in vitro ( Supplementary Information, Fig. S1a ), they resumed proliferation after -LT-Cre cells showed normal expression of Rap1 exons 1 and 2, and of the messenger RNA for Kars, an essential gene 18 that shares a promoter with Rap1 (Fig. 1d) , whereas Rap1 E3 transcripts were undetectable. Rap1
Δ/Δ -LT-Cre cells lacked expression of full-length Rap1 protein as determined by western blot analysis and immunofluorescence microscopy ( Fig. 1e-g ), but we detected a low-abundance protein of relative molecular mass 40,000 (M r 40K) that might correspond to a truncated Rap1 protein (Rap1Δ; Fig. 1e, f) . Rap1Δ was undetectable in nuclear extracts (Fig. 1e ), in agreement with deletion of the NLS and RCT regions. On the basis of the low and cytoplasmic expression of Rap1Δ, it is unlikely that it might exert dominant-negative effects at telomeres in Rap1-null cells, although potential effects on other cellular pathways cannot be discounted.
Rap1 abrogation does not disrupt binding of other shelterins to telomeres
In chromatin fractionation assays, binding of TRF1, TRF2, POT1, TPP1 and TIN2 to chromatin was normal in Rap1-null cells, and no binding of Rap1Δ was observed (Fig. 2a, b) . As control, histone H3 showed normal binding to chromatin in both genotypes (Fig. 2a) . By using chromatin immunoprecipitation (ChIP) assays (Fig. 2c, d ), as well as immunofluorescence staining (Fig. 2e) , we confirmed normal binding of TRF1, TIN2, TRF2 and TPP1 to Rap1-depleted telomeres.
No fusions but increased telomere fragility and recombination in Rap1-null cells To measure DNA damage at telomeres in the absence of Rap1, we determined their co-localization with γ-H2AX foci, the so-called telomere dysfunction induced foci (TIFs) 19, 20 . Rap1 deletion 21 ( Supplementary  Information, Fig. S1e , f) resulted in more than 70% of Rap1 Δ/Δ cells showing more than three TIFs per metaphase, whereas these events were rare in control cells (Fig. 3a, b ). CHK1 and CHK2 checkpoint kinases were phosphorylated in Rap1 Δ/Δ cells but not in WT cells (Fig. 3c, d ). As control, TRF1-null cells showed robust activation of these kinases 14 ( Fig. 3d ). Chemical inhibition of CHK1 and CHK2 rescued cells with DNA damage as well as cells showing more than three TIFs ( Supplementary  Information, Fig. S1g-i) , indicating activation of both DNA damage pathways.
Rap1 deletion did not lead to increased telomere fusions in MEFs (Fig. 3e) . Instead, Rap1-deleted MEFs showed increased frequencies of chromosome ends with more than one telomere signal or multitelomeric signals (MTS, Fig. 3f ), which have recently been related to telomere fragility 14, [22] [23] [24] . MTSs were increased in WT MEFs treated with drugs that induce telomere fragility, such as aphidicolin, and were increased further in similarly treated Rap1-deficient MEFs (Fig. 3f) . Chromosome breaks and complex aberrations were also increased in aphidicolin-treated Rap1-null MEFs in comparison with WT controls ( Supplementary  Information, Fig. S1j-k) .
Sister telomere recombination event frequencies were elevated in Rap1 Δ/Δ -Cre-LT MEFs compared with WT controls (Fig. 3g, h ), supporting a role for Rap1 in preventing telomere recombination Mice with Rap1 deletion in stratified epithelia are viable but develop skin hyperpigmentation in adulthood We targeted Rap1 deletion to stratified epithelia in Rap1 Fig. 4a ) 26, 27 . These mice show excision of Rap1 E3 in the epidermis but not in the dermis (Fig. 4a ), in agreement with K5-Cre expression 27 .
Accordingly, Rap1 immunofluorescence was undetectable in Rap1
Δ/Δ K5-Cre epidermis (Fig. 4b, c) . 
Preferential derepression of subtelomeric genes in Rap1
Δ/Δ cells To address a role for Rap1 in S gene regulation, we performed gene expression analysis of WT and Rap1-null MEFs. We predefined S regions as the 3-megabase-pair (Mbp) regions adjacent to telomeres, which allowed us to recruit a robust number of genes (Fig. 5a ). Genes in S regions showed significant differences in transcriptional activity from those of non-subtelomeric (NS)-region genes (P = 1.044 × 10 -5
; Fig. 5a ). In both gene sets, the median distribution of log 2 (Rap1 Δ/Δ /Rap1 +/+ ) values was displaced from zero ( Fig. 5a ), indicating a genome-wide effect of Rap1 deletion on gene expression. This effect was more pronounced in S regions than in NS regions (0.04 versus 0.01, respectively; Fig. 5a ). Moreover, S regions in Rap1-deficient cells were significantly overexpressed compared with those in WT cells (P < 10 Rap1 transcriptional networks include cell adhesion, cancer and metabolism Apart from changes in S gene expression, a stringent (FDR < 0.15) differential gene expression analysis revealed 15 genes that were significantly downregulated and one gene that was significantly upregulated in Rap1-null MEFs (FDR < 0.15) ( Fig. 6a ; Supplementary Information, Tables S1 and S2). All 16 differentially expressed genes (DEGs) were validated by quantitative PCR (qPCR) (Fig. 6b) . Rap1 was the most downregulated gene (more than eightfold by microarray analysis, and more than 200-fold by qPCR analysis) ( Fig. 6a, b ; Supplementary Information, Table S1 ), whereas the rest of the DEGs changed more than fourfold (-2 > log 2 FC > 2; (FC, fold change), Supplementary Information, Table S1 ). Eight of the 16 DEGs are related to cancer, as indicated by GSEA (Fig. 6a-c) .
GSEA and Gene Ontology (GO) analysis on genes dowregulated at least twofold in Rap1-null MEFs (log 2 FC < -1) extended the analysis to a total of 478 genes (Supplementary Information, Tables S3 and S4-S6), including Igf2 (Fig. 6b) . The downregulated genes H19 and Igf2 ( Tables S3 and S7 ). GSEA analysis also revealed significant downregulation of genes involved in cell adhesion and metabolism in Rap1-null cells ( Supplementary Information, Fig. S4b-f; Supplementary Information, Tables S8-S11). These included genes of the insulin secretion, peroxisome-proliferator-activated receptor signalling and growth hormone pathways, including Igf2 (Fig. 6b) . In turn, Rap1-null cells Table S12 ).
Two highly downregulated genes in Rap1-null cells, namely those encoding NNMT (nicotinamide N-methyltransferase) and CTGF (connective tissue growth factor) (Fig. 6a, b) , were recently found to be upregulated in calorie-restricted (CR) mice 31 .
Comparison of the CR gene set 31 with genes downregulated in Rap1-null MEFs indicated that the CR gene set is significantly downregulated in Rap1-null cells (Supplementary Information, Table S13), with both gene sets showing an inverse pattern (Fig. 6d) . This includes PGC1α, a regulator of lipid metabolism 32 , also confirmed by qPCR (Fig. 6e) . Together, these results indicate that absence of Rap1 leads to changes in gene expression with a predicted negative impact on metabolism.
Rap1
Δ/Δ
K5-Cre females show increased body weight Rap1
Δ/Δ K5-Cre female mice weighed about 10% more than age-matched WT littermates from 14 weeks of age onwards, a phenotype not observed in males ( Fig. 4d; Supplementary Information, Fig. S4g, h ). To address whether this was related to abnormal expression of metabolic genes on Rap1 abrogation, we subjected male and female mice to either a standard diet (SD) or a high-fat diet (HFD) ( Supplementary Information, Fig. S4i, j) . Whereas WT and Rap1 Δ/Δ K5-Cre male mice gained weight on a HFD compared with those on a SD, Rap1 Δ/Δ K5-Cre females on a SD gained weight at the same rate as WT females on a HFD with similar food intake ( Supplementary Information, Fig. S4i-k) , and this was not increased by placing them on a HFD. Thus, Rap1 deletion in females phenocopies exposure to a HFD. A similar phenotype of increased female body weight is reported for PGC1α deficiency 33 .
Mapping in vivo Rap1-binding sites by using ChIP sequencing We next sought to determine the in vivo Rap1-binding loci to the chromatin by using whole-genome ChIP sequencing (ChIP-seq) ( Supplementary  Information, Fig. S5a ). Rap1-null MEFs were used as a control for Rap1 peak specificity. More than 2.1 × 10 7 and 1.7 × 10 7 uniquely mapped 36 base reads were collected for WT and Rap1-null cells, respectively ( Supplementary  Information, Table S14 ). Supporting the notion of binding of Rap1 to telomeres, we found a strong over-representation of raw 36-base-pair (bp) sequences containing the telomeric TTAGGG 5 repeat in WT ChIP-seq compared with that in Rap1-null controls, which showed similar levels to input DNA (Fig. 7a) . This difference was not observed with non-telomeric repeats ( Supplementary Information, Table S15 ; Supplementary  Information, Fig. S5b ). We also found perfect permutations of at least two telomeric repeats in extratelomeric Rap1-binding sites, in a frequency 32-fold higher (P < 2.2 × 10 -16 ) than in the mouse genome ( Fig. 7b; Supplementary  Information, Fig. S5c ). Between 2% and 4% of all the genomic occurrences of telomeric repeats are occupied by Rap1-binding sites ( Supplementary  Information, Fig. S5d ). When allowing one mismatch, the TTAGGG motif was found at least once in up to 37.2% of the Rap1 peak sequences ( Supplementary Information, Fig. S5e, f) , suggesting that Rap1 binds to nontelomeric regions enriched in telomeric repeats. In total, 30,398 non-telomeric binding sites (average peak width 75 bp) were identified in the WT and Rap1-null comparison at the 10% FDR level (see Supplementary Information, Fig. S6a for peaks at the 5% and 1% FDR levels). Rap1 sites were found throughout the genome ( Supplementary Information, Fig. S6b ) with a noticeable enrichment at the S regions (17.45 sites per Mbp) (Fig. 7c) compared with the genome-wide nature cell biology VOLUME 12 | NUMBER 8 | AUGUST 2010density (11.71 sites per Mbp). The density of subtelomeric Rap1 peaks decreased proportionally to the distance from the telomere, suggesting a gradient of Rap1 binding from telomeres into the S regions (Fig. 7d) . The same trend was observed for the genomic distribution of (TTAGGG) 2 repeats ( Supplementary Information, Fig. S6c ). Both signals showed a mild correlation (r = 0.46; Supplementary Information, Fig. S6d ), which was increased in regions closer to telomeres (r = 0.89; Supplementary  Information, Fig. S6d) , suggesting a preference for repeat-mediated Rap1 binding at subtelomeres and possible alternative binding mechanisms for the rest of the genome. The X chromosome showed the lowest density of Rap1-binding sites (2.65 Rap1 sites per Mbp; Supplementary Information,  Fig. S6e) , which was not attributable to differences in karyotype (all MEFs were XY). Accordingly, genes located in the X chromosome suffered fewer expression changes in Rap1-null cells than genes in other chromosomes ( Supplementary Information, Fig. S6f ).
Up to 22,384 individual Rap1-binding sites (73.63%) could be associated with genes, either mapping inside the gene structure (13,057 sites (42.95%)) or in 10 kbp surrounding the gene transcription limits (9,327 sites (30.68%)) ( Supplementary Information, Fig. S7a ). The remaining 8,014 sites (26.36%) were considered to be intergenic ( Supplementary  Information, Fig. S7a ). The increased density of Rap1 peaks around gene-coding regions resembles that of known transcription factors. Given that coding genes and their 10-kbp neighbour regions span about 47% of the mouse genome, this observation discards randomness in the topology of extratelomeric Rap1 binding distribution (P < 2.2 × 10 Table S16 ). Significantly downregulated genes in Rap1-null cells containing Rap1 peaks included Rap1 itself, Hic1 (downregulated fourfold), Fgf5 (downregulated fivefold) and Ctgf (downregulated sevenfold) (Figs 6a, b and 7f; Supplementary Information, Table S16 ). We also found strong Rap1-binding sites not associated with genes ( Fig. 7h , peak in chromosome 2). When comparing deregulated versus non-deregulated genes with peaks, we found that the peak presence-gene deregulation dependence is significant (P = 0.0003), supporting a non-random relationship between Rap1 binding and transcriptional gene regulation.
Identification of a consensus Rap1-binding sequence to extratelomeric sites To determine the sequence specificity of extratelomeric mammalian Rap1 binding, we used the de novo motif discovery algorithm Weeder 34 on the top over-represented Rap1-binding peaks (n = 30). The highestranking motif was (TTAGGG) 2 (Fig. 8a) . Over-representation of the telomeric motif was found in the top 1,000 and top 100 ranking peaks ( Supplementary Information, Fig. S7b) , with Rap1 peaks in chromosomes 11 and 17 showing more than 20 TTAGGG tandem repeats and the top ranking peak corresponding to a perfect (TTAGGG) 8 repeat at chromosome 2 ( Fig. 7f; Supplementary Information, Fig. S7b ). This over-representation is evident in the peak sequences compared with the aligned WT reads ( Supplementary Information, Fig. S7c, d ). When examining strongly deregulated genes, including the Ctgf and Fgf5 genes ( Supplementary Information, Table S17 ), Olfm1, Crabp1
and Angptl4, we found the telomeric consensus motif in their Rap1 binding peaks ( Supplementary Information, Fig. S7e ; Supplementary Information, Table S17 ). We detected imperfect telomeric motifs in the peak sequences associated with half (51.44%) of DEGs (Supplementary  Information, Table S17 ), a proportion similar to Rap1 peaks in nonderegulated genes (P = 0.31). Given the significant association between Rap1 peaks and gene deregulation, these results suggest the participation of Rap1 in alternative regulation mechanisms not mediated by telomeric repeat binding.
To explore non-TTAGGG-rich putative Rap1-binding motifs we discarded the top ranking peaks with at least three telomeric repeats. No clear consensus, apart from heterogeneous A/T-rich sequences common for many transcription factors, was obtained ( Supplementary  Information, Table S18 ).
For ChiP-seq validation, we chose 14 Rap1-binding peaks located at both non-coding chromatin (chromosomes 2, 3 and 17) and at deregulated genes in Rap1-null versus WT MEFs ( Fig. 8b; Supplementary Information,  Fig. S7e ; Supplementary Information, Table S15 ). ChIP-qPCR showed Rap1 binding to these regions, and this was decreased in Rap1-null cells (Fig. 8b) . No specific Rap1 binding was detected at chromatin regions not containing Rap1-binding sites (NC1 and NC2; Fig. 8b ).
To address whether Rap1 binding to genes affects their transcriptional activity, we placed Rap1-binding sites of Ctgf, Hic1 and Angptl4 upstream of a minimal promoter driving luciferase expression (Fig. 8c) . Luciferase activity was significantly decreased in Rap1 Δ/Δ cells compared with that in WT cells for all constructs; no differences were observed with the empty vector. These results suggest Rap1-dependent enhancer activity in these regions and support a role for Rap1 in transcriptional regulation.
Because Rap1 is recruited to telomeres by TRF2 (ref.
3), we addressed whether TRF2 was able to bind to TTAGGG-rich extratelomeric Rap1-binding sites. As determined by ChIP, TRF2 was bound to peaks in chromosomes 2 and 17, and this binding was independent of Rap1 ( Fig. 8d) . TRF2 did not bind to the Rap1 peak within the Crabp1 promoter (Fig. 8d) , with a degenerate telomeric repeat ( Supplementary  Information, Fig. S7e ). Thus, Rap1 is likely to be recruited to TTAGGGrich extratelomeric regions by TRF2 (peaks at chromosomes 2 and 17), whereas other factors may mediate Rap1 recruitment to degenerate telomeric repeats at the Crabp1 promoter.
DIsCussIoN
Here we have described cells and mice deleted for Rap1. Whereas previous studies support a Rap1-dependent pathway for protection against telomere fusions 35, 36 , our results suggest that chromatin-bound Rap1 does not significantly inhibit end-to-end fusions in MEFs. Instead, Rap1 significantly prevents telomere fragility 14, 24 and telomere recombination. This is in agreement with a recent report showing a role for Rap1 in preventing telomere recombination but not fusions 13 . In agreement with normal telomere capping, mice with targeted Rap1 deletion to stratified epithelia are viable and only show mild skin hyperpigmentation in adulthood. This is in marked contrast to 100% perinatal lethality and severe skin morphogenesis defects in similarly generated TRF1-null and TPP1-null mice, with severe telomere capping defects 14, 15 . Rap1-deleted MEFs and mice showed shorter telomeres than in controls, which was more apparent in proliferating tissues (namely the skin basal layer). Shorter telomeres and skin hyperpigmentation in Tpp1-null skin is analogous with the situation in human patients with short telomeres due to telomerase mutations [37] [38] [39] [40] [41] , who also show skin hyperpigmentation. As Rap1-null cells have normal telomerase expression, accelerated telomere shortening in Rap1-null epidermis may result from increased telomere recombination and fragility, although a role of Rap1 in TERT recruitment to telomeres cannot be discounted.
Yeast scRap1 and Trypanosoma brucei tpRap1 silence genes located near the telomeres 6, 42 . Here we find preferential upregulation of genes located in subtelomeric positions in Rap1-deficient cells in comparison with WT controls, suggesting a conserved role of Rap1 in S gene silencing.
We show that Rap1-dependent transcriptional changes also include genes involved in cancer, cell adhesion, and metabolism. In particular, Rap1 deletion leads to changes in gene expression with a predicted negative impact on metabolism, in agreement with an increased-body-weight phenotype in Rap1-null females. Transcriptional changes induced by Rap1 deletion are different from those associated with severe telomere dysfunction 43 ; it is therefore unlikely that Rap1-dependent transcriptional effects at subtelomeres and elsewhere in the genome are due to mild telomere dysfuction induced by Rap1 deletion.
By using ChIP-seq, we have demonstrated that Rap1 binds to telomeric repeats and to extratelomeric sites through recognition of the (TTAGGG) 2 consensus motif (Fig. 8e) . Extratelomeric Rap1-binding sites are enriched at S regions, and this enrichment decreases proportionally to the distance from the telomeres, providing a mechanism by which mammalian Rap1 can influence S gene regulation. In addition, Rap1-binding sites are present in a significant percentage (31%) of the differentially regulated genes in Rap1-deficient cells, supporting a role of Rap1 in transcriptional gene regulation. Rap1 also binds to intergenic regions with many tandem telomeric repeats. The relevance of Rap1 binding to these internal telomeric repeats is unclear although, by analogy with telomeres, Rap1 may prevent recombination and fragility at these sites.
In summary, we have described both telomeric and non-telomeric roles for mammalian Rap1. Although non-telomeric roles have also previously been shown for TERT and other shelterins 25, [44] [45] [46] [47] [48] , our results provide evidence for a shelterin component influencing gene transcription through binding to non-telomeric sites. We further show that TRF2 binds to Rap1 peaks containing perfect repeats but not to those with degenerate repeats, by analogy with Rap1 recruitment to telomeres by TRF2 (ref. 3) . Future studies merit the identification of factors responsible for Rap1 recruitment to non-TTAGGG-rich chromatin regions.
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